Stocks to Buy: Citi projects 20% upside for a stock that Mutual Funds lapped up in March
Not only did Mutual Funds increase their stake in Anthem Biosciences in a significant proportion during the March quarter, the stock is also a consensus "buy" among analysts who cover it.
Not only did Mutual Funds increase their stake in Anthem Biosciences in a significant proportion during the March quarter, the stock is also a consensus "buy" among analysts who cover it.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2249461921-9d6cb804a1a44f389d460166fa9dd343.jpg?#)
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
